Record High for Applied Nutrition Shares
Applied Nutrition has seen its shares reach a record high, driven by strong performance and strategic moves. The company, backed by Coleen Rooney, reported that demand for its protein powders continues to grow without any signs of slowing down.
The business revealed that its trading for the year ending 31 July is “running ahead of expectations,” despite earlier concerns about the impact of the war in the Middle East. As a result, it now anticipates annual sales of approximately £148 million, surpassing the £140 million forecast in March.
On Monday afternoon, shares rose by 6.7% to 260p. This marks a significant increase since the company’s listing on the London market in October 2024, during which it raised £350 million in a successful float.
Thomas Ryder, the founder and CEO of Applied Nutrition, who previously worked as a scaffolder in Liverpool before starting the business in 2014, commented:
“Demand across our markets shows no sign of abating and we are well positioned to deliver on what consumers need for their health and wellness journey.
As an agile but disciplined business, we’re confident that our delivery and expansion will continue to underpin the long-term outlook for our business.”
Strategic Acquisitions and Partnerships
In addition to its strong financial performance, Applied Nutrition has made several strategic moves to strengthen its position in the market. It recently paid £12 million to acquire US-based sports nutrition manufacturer Nutrablend Group. This acquisition includes a warehouse in Buffalo, New York, as well as two brands—Basic and GR8 Lifestyle.
This move is expected to significantly enhance the company’s footprint in the US market. It also brings with it the potential for up to £222 million in annual sales in the region, while reducing US freight and logistics costs.
The company has also entered into a new licensing agreement with Mondelez, the owner of Cadbury, to develop sports nutrition products using the branding of popular sweets, Sour Patch Kids. This follows a history of successful collaborations, including partnerships with Slush Puppie, Swizzels Love Hearts, and Vimto.
Applied Nutrition is also known for its range of Marine Collagen supplements, which are promoted by Coleen Rooney. Rooney increased her stake in the company in February, expressing her happiness with the investment. Although she did not disclose the exact percentage, it is believed to be below 3%.
Addressing Market Concerns
Despite maintaining its sales guidance, the company had previously warned investors about potential reductions in sales volumes in the Middle East. In March, it stated that it was aware of the disruption to shipping routes and purchasing activities in the region, expecting “some reduction in volumes into the region during the second half.”
However, Monday’s update has reassured investors, showing confidence in the company’s ability to navigate these challenges.
Expanding Product Offerings
Another factor contributing to the company’s success is the growing popularity of weight-loss drugs, such as Ozempic. These medications, medically known as GLP-1s, can lead to muscle mass loss alongside fat, prompting doctors to recommend strength training and increased protein intake.
Applied Nutrition has responded by launching a range of 53 protein-focused meals and snacks in partnership with supermarket Morrisons. This initiative targets consumers who are using these weight-loss drugs and looking for balanced nutrition options.
Leadership and Ownership
Thomas Ryder remains a key figure in the company, holding a 34% stake valued at £152 million. His leadership and strategic vision have played a crucial role in the company’s growth and continued success.
